I would have thought Chinese & NZ relations gone sour would benefit Ballemy''s as A2M would in all probability loose traction as a result... Why poor us?
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025